July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Development Of A Screening Platform To Identify Factors That Promote Retinal Regeneration In Mice
Author Affiliations & Notes
  • Sankarathi Balaiya
    Vanderbilt Eye Institute, Vanderbilt University Medical center, Nashville, Tennessee, United States
  • Wendi S Lambert
    Vanderbilt Eye Institute, Vanderbilt University Medical center, Nashville, Tennessee, United States
  • Bryan A Millis
    Cell Imaging Shared Resource, Vanderbilt University, Nashville, Tennessee, United States
    Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee, United States
  • David J Calkins
    Vanderbilt Eye Institute, Vanderbilt University Medical center, Nashville, Tennessee, United States
  • Edward M Levine
    Vanderbilt Eye Institute, Vanderbilt University Medical center, Nashville, Tennessee, United States
    Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee, United States
  • Footnotes
    Commercial Relationships   Sankarathi Balaiya, None; Wendi Lambert, None; Bryan Millis, None; David Calkins, None; Edward Levine, None
  • Footnotes
    Support  NEI U01-EY27265; Unrestricted grant to Vanderbilt Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness, Inc
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 3109. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sankarathi Balaiya, Wendi S Lambert, Bryan A Millis, David J Calkins, Edward M Levine; Development Of A Screening Platform To Identify Factors That Promote Retinal Regeneration In Mice. Invest. Ophthalmol. Vis. Sci. 2018;59(9):3109.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose :
We are developing an in vivo screening platform in mice to identify novel regeneration-promoting factors. Because an in vivo approach is low throughput and regeneration could be limited to a small number of cells, it is critical to rapidly visualize and quantify changes in Muller Glia/MG properties (proliferation, location, morphology, gene expression) in the whole retina and at cellular resolution. Here, we describe our efforts at achieving this following genetic stimulation of MG proliferation through MG-specific inactivation of the cell cycle regulator p27Kip1.

Methods : Adult p27Kip1(flox); Rlbp1:CreER mice received a single dose of tamoxifen (25µg/gbw). After 7 days, 5-ethynyl-2'-deoxyuridine/EdU (30µg/gbw) was given 3 times over 3 days. Retinas were subsequently harvested and fixed. EdU was detected with click-it chemistry and retinas were cleared by ScaleSQ. Flattened retinas were imaged using a multi-dimensional large image stitching approach with a fully automated widefield fluorescence microscope equipped and high speed large format sCMOS detector. 25 plane image-stacks were captured at 4 µm intervals to yield 100 µm depth throughout the entire tissue. Focus-stacking (Extended Depth of Focus/EDF) yielded a single plane of focused information per dataset. A custom script was validated and deployed to perform automated image segmentation and cell-number quantification.

Results : EdU detection through the entire retina was achieved by extending the permeabilization and click-it reaction times. ScaleSQ restored the optical transparency of the retina within 2 hours, significantly reducing light scatter while preserving fluorescent signals. The superfast, high resolution imaging permitted the capture of as many as 3000 images per retina in less than one hour and EDF reduced the image collection to a single focused image suitable for quantification. Automated counting achieved a concordance of >85% when compared to manual counting.

Conclusions : We have developed a tissue and image processing pipeline that significantly streamlines the analysis of whole retinas, thereby increasing the feasibility of screening in an in vivo context. We are currently adapting this approach to work with antibody- and reporter-based detection methods.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×